Back
Avidity Biosciences Stock Price Chart
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
28
RNA
Avidity Biosciences
Last Price:
42.16
Seasonality Move:
39.98%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNA is experiencing selling pressure, which indicates risk of future bearish movement.
Avidity Biosciences Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.51 | Sell |
| 20-day SMA: | 45.87 | Sell |
| 50-day SMA: | 45.1 | Sell |
| 200-day SMA: | 34.2 | Buy |
| 8-day EMA: | 46.84 | Sell |
| 20-day EMA: | 46.32 | Sell |
| 50-day EMA: | 45.24 | Sell |
| 200-day EMA: | 35.58 | Buy |
Avidity Biosciences Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.53 | Buy |
| Relative Strength Index (14 RSI): | 42.17 | Sell |
| Chaikin Money Flow: | -1839481 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.78 - 48.76) | Sell |
| Bollinger Bands (100): | (41.56 - 46.96) | Sell |
Avidity Biosciences Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Avidity Biosciences Stock
Is Avidity Biosciences Stock a Buy?
- Avidity Biosciences share price is 42.18 while RNA 8-day simple moving average is 47.51, which is a Sell signal.
- The stock price of RNA is 42.18 while Avidity Biosciences 20-day SMA is 45.87, which makes it a Sell.
- Avidity Biosciences 50-day simple moving average is 45.10 while RNA share price is 42.18, making it a Sell technically.
- RNA stock price is 42.18 and Avidity Biosciences 200-day simple moving average is 34.20, creating a Buy signal.
RNA Technical Analysis vs Fundamental Analysis
Sell
28
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy or a Sell?
-
Avidity Biosciences stock is rated a Sell
The current Avidity Biosciences [RNA] share price is $42.18. The Score for RNA is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
Avidity Biosciences Stock Info
Market Cap:
5.03B
Price in USD:
42.18
Share Volume:
2M
Avidity Biosciences 52-Week Range
52-Week High:
56.00
52-Week Low:
5.68
Sell
28
Avidity Biosciences (RNA)
is a Sell
Avidity Biosciences Share Price Forecast
-
What is the Avidity Biosciences stock price today?
The Avidity Biosciences stock price is 42.18 USD today. -
Will RNA stock go up or go down?
Avidity Biosciences> share price is forecast to RISE/FALL based on technical indicators -
Is Avidity Biosciences overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Avidity Biosciences is overvalued.
Is Avidity Biosciences Stock a Buy?
- Avidity Biosciences share price is 42.18 while RNA 8-day exponential moving average is 46.84, which is a Sell signal.
- The stock price of RNA is 42.18 while Avidity Biosciences 20-day EMA is 46.32, which makes it a Sell.
- Avidity Biosciences 50-day exponential moving average is 45.24 while RNA share price is 42.18, making it a Sell technically.
- RNA stock price is 42.18 and Avidity Biosciences 200-day simple moving average is 35.58, creating a Buy signal.
Fundamental Analysis of Avidity Biosciences
Is Avidity Biosciences a good investment?
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and a decrease next year of $0.25 per share.
Technical Analysis of Avidity Biosciences
Should I short Avidity Biosciences stock?
- RNA Moving Average Covergence Divergence (MACD) indicator is 0.53, suggesting Avidity Biosciences is a Buy
- Avidity Biosciences Relative Strength Index (RSI) is 42.17, which suggest Avidity Biosciences is oversold
- The Bollinger Bands (25) for Avidity Biosciences is (43.78 - 48.76), which suggest Avidity Biosciences is a Sell
- The Bollinger Bands (100) for Avidity Biosciences is (41.56 - 46.96), which suggest Avidity Biosciences is a Sell
* Avidity Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.